BRIEF-Diurnal Group says primary endpoint met in Infacort late-stage study
 

BRIEF-Diurnal Group says primary endpoint met in Infacort late-stage study
* Positive headline data from pivotal study for Infacort in Europe for paediatric adrenalinsufficiency (AI)http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...f8:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...f8:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/zwQyEiRGnDo